EG

Emerging Growth Management

Description

Emerging Growth Management

Investor Profile

Emerging Growth Management has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Health Diagnostics, Health Care, Biotechnology.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Diagnostics
  • Health Care
  • Biotechnology
  • Genetics
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Emerging Growth Management frequently co-invest with?

Morgan Stanley Dean Witter
North America, New York, United States, New York
Co-Investments: 1
EK
North America, New York, United States, Rochester
Co-Investments: 1
Acacia Research
North America, New York, United States, New York
Co-Investments: 1
OC
North America, California, United States, San Francisco
Co-Investments: 1
QP
Oceania, New South Wales, Australia, Bondi
Co-Investments: 1
JC
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Emerging Growth Management?

R2 Technology

Santa Clara, California, United States

R2 Technology develops and commercializes computer-aided detection systems for the early-detection of breast cancer.

Health CareHealth Diagnostics
Series UnknownJan 2, 2001
Amount Raised: $16,000,000
CombiMatrix

Irvine, California, United States

CombiMatrix develops proprietary technologies, products and services for drug development, genetic analysis, molecular diagnostics and more.

BiotechnologyGeneticsHealth DiagnosticsPharmaceutical
Series UnknownAug 4, 2000
Amount Raised: $36,000,000